Annual SG&A
$303.88 M
-$28.25 M-8.51%
31 December 2023
Summary:
Bioventus annual selling, general & administrative expenses is currently $303.88 million, with the most recent change of -$28.25 million (-8.51%) on 31 December 2023. During the last 3 years, it has risen by +$110.80 million (+57.39%). BVS annual SG&A is now -8.51% below its all-time high of $332.13 million, reached on 31 December 2022.BVS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$81.09 M
-$13.70 M-14.45%
28 September 2024
Summary:
Bioventus quarterly selling, general & administrative expenses is currently $81.09 million, with the most recent change of -$13.70 million (-14.45%) on 28 September 2024. Over the past year, it has increased by +$11.27 million (+16.14%). BVS quarterly SG&A is now -14.45% below its all-time high of $94.78 million, reached on 29 June 2024.BVS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.35 B
-$39.48 M-3.01%
28 September 2024
Summary:
Bioventus TTM selling, general & administrative expenses is currently -$1.35 billion, with the most recent change of -$39.48 million (-3.01%) on 28 September 2024. Over the past year, it has dropped by -$1.66 billion (-546.49%). BVS TTM SG&A is now -10768.25% below its all-time high of $335.58 million, reached on 01 September 2022.BVS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.5% | +16.1% | -546.5% |
| 3 y3 years | +57.4% | +16.4% | -674.8% |
| 5 y5 years | +58.5% | +101.8% | -3466.2% |
BVS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.5% | +57.4% | -14.4% | +16.4% | <-9999.0% | at low |
| 5 y | 5 years | -8.5% | +58.5% | -14.4% | +133.8% | <-9999.0% | at low |
| alltime | all time | -8.5% | +106.6% | -14.4% | +133.8% | <-9999.0% | at low |
Bioventus Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $81.09 M(-14.4%) | $332.64 M(+3.5%) |
| June 2024 | - | $94.78 M(+20.9%) | $321.37 M(+6.6%) |
| Mar 2024 | - | $78.41 M(+0.1%) | $301.43 M(-0.8%) |
| Dec 2023 | $303.88 M(-8.5%) | $78.36 M(+12.2%) | $303.88 M(+0.3%) |
| Sept 2023 | - | $69.82 M(-6.7%) | $302.96 M(-2.9%) |
| June 2023 | - | $74.84 M(-7.4%) | $312.09 M(-4.5%) |
| Mar 2023 | - | $80.86 M(+4.4%) | $326.87 M(-1.6%) |
| Dec 2022 | $332.13 M(+30.6%) | $77.44 M(-1.9%) | $332.13 M(-1.0%) |
| Sept 2022 | - | $78.95 M(-11.9%) | $335.58 M(+2.9%) |
| June 2022 | - | $89.62 M(+4.1%) | $326.26 M(+6.7%) |
| Mar 2022 | - | $86.12 M(+6.5%) | $305.69 M(+20.2%) |
| Dec 2021 | $254.25 M | $80.88 M(+16.1%) | $254.25 M(+8.0%) |
| Sept 2021 | - | $69.64 M(+0.8%) | $235.35 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $69.05 M(+99.1%) | $216.00 M(+15.2%) |
| Mar 2021 | - | $34.69 M(-44.0%) | $187.49 M(-2.9%) |
| Dec 2020 | $193.08 M(-2.7%) | $61.97 M(+23.2%) | $193.08 M(+4.1%) |
| Sept 2020 | - | $50.30 M(+24.1%) | $185.56 M(+37.2%) |
| June 2020 | - | $40.53 M(+0.6%) | $135.26 M(+42.8%) |
| Mar 2020 | - | $40.28 M(-26.0%) | $94.73 M(+74.0%) |
| Dec 2019 | $198.47 M(+3.5%) | $54.45 M(+35.5%) | $54.45 M(+35.5%) |
| Dec 2018 | $191.67 M(+29.1%) | - | - |
| Mar 2016 | - | $40.18 M(+7.8%) | $40.18 M(+7.8%) |
| Dec 2015 | $148.44 M(+0.9%) | - | - |
| Mar 2015 | - | $37.27 M | $37.27 M |
| Dec 2014 | $147.06 M(-2.2%) | - | - |
| Dec 2013 | $150.37 M | - | - |
FAQ
- What is Bioventus annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bioventus?
- What is Bioventus annual SG&A year-on-year change?
- What is Bioventus quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bioventus?
- What is Bioventus quarterly SG&A year-on-year change?
- What is Bioventus TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bioventus?
- What is Bioventus TTM SG&A year-on-year change?
What is Bioventus annual selling, general & administrative expenses?
The current annual SG&A of BVS is $303.88 M
What is the all time high annual SG&A for Bioventus?
Bioventus all-time high annual selling, general & administrative expenses is $332.13 M
What is Bioventus annual SG&A year-on-year change?
Over the past year, BVS annual selling, general & administrative expenses has changed by -$28.25 M (-8.51%)
What is Bioventus quarterly selling, general & administrative expenses?
The current quarterly SG&A of BVS is $81.09 M
What is the all time high quarterly SG&A for Bioventus?
Bioventus all-time high quarterly selling, general & administrative expenses is $94.78 M
What is Bioventus quarterly SG&A year-on-year change?
Over the past year, BVS quarterly selling, general & administrative expenses has changed by +$11.27 M (+16.14%)
What is Bioventus TTM selling, general & administrative expenses?
The current TTM SG&A of BVS is -$1.35 B
What is the all time high TTM SG&A for Bioventus?
Bioventus all-time high TTM selling, general & administrative expenses is $335.58 M
What is Bioventus TTM SG&A year-on-year change?
Over the past year, BVS TTM selling, general & administrative expenses has changed by -$1.66 B (-546.49%)